A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.

NACompletedINTERVENTIONAL

Enrollment

231

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions

Tobacco Use

Interventions

OTHER

OTDN product 1

Oral tobacco-derived nicotine product

OTHER

OTDN product 2

Oral tobacco-derived nicotine product

OTHER

Tobacco Cessation

Trial Locations (2)

QPS Bio-Kinetic Clinical Applications, LLC, Springfield

Inflamax - Hill Top Research, Neptune City

All Listed Sponsors

lead

Altria Client Services LLC

INDUSTRY

NCT03692078 - A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products. | Biotech Hunter | Biotech Hunter